secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001683168-24-006850
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical shareholders approve 3M share increase to 2020 Equity Plan; all director nominees elected
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2020 Equity Incentive Plan, increasing authorized shares by 3,000,000 to total 3,364,256 shares.
- Five directors elected: Broenniman, Frakes, Gikakis, Rossetti, Shah, each with over 2.9M votes for.
- Ratification of Haskell & White LLP as independent auditor approved: 4.70M for, 163,731 against.
- Non-binding advisory vote on executive compensation approved: 2.76M for, 245,575 against.
- Plan amendment effective September 27, 2024, after receiving stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316824006850/0001683168-24-006850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316824006850/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-006850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer